search
Back to results

Improving Post-Operative Pain and Recovery in Gynecologic Surgery

Primary Purpose

Postoperative Pain, Opioid Use, Acetaminophen

Status
Completed
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Rectal acetaminophen
Intravenous acetaminophen
Sponsored by
Aultman Health Foundation
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Postoperative Pain focused on measuring Postoperative Pain, Minimally-invasive Hysterectomy, Opioid Use, Acetaminophen, Hysterectomy

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Willing to consent
  • Amendable to receive either rectal or intravenous acetaminophen
  • Planned hospital stay for at least 24 hours.

Exclusion Criteria:

  • Patients unable to provide informed consent
  • Patients with a history of regular opioid use prior to surgery based on their current home medication list
  • Patients who have required regular opioid intake for the 7 days preceding surgery
  • Patients with known hypersensitivity to acetaminophen
  • Patients with a baseline preoperative liver function enzymes (AST and ALT) that are greater than twice the upper limits
  • Unable to complete procedure as planned.

Sites / Locations

  • Aultman Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Rectal acetaminophen

Intravenous acetaminophen

Arm Description

Patients will receive two 650mg suppositories rectally of acetaminophen for a total dose of 1300mg at the end of surgery.

Patients will receive one dose of 1000mg of acetaminophen, administered intravenously, at the end of surgery.

Outcomes

Primary Outcome Measures

Postoperative Pain: Standardized Pain Scale
Post-operative pain control using a standardized pain scale from 0 (no pain) to 10 (worse pain) measured every 4 hours for the 24 hours, or discharge, whichever comes first. Time points were averaged for each participate and reported as a single value.

Secondary Outcome Measures

Opioid Use
Total amount of opioid rescue calculated by converting all opiates to Morphine Milligram Equivalents in the first 24 hours following surgery, or upon discharge, whichever comes first.

Full Information

First Posted
November 21, 2019
Last Updated
January 18, 2022
Sponsor
Aultman Health Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT04175509
Brief Title
Improving Post-Operative Pain and Recovery in Gynecologic Surgery
Official Title
Improving Post-Operative Pain and Recovery in Gynecologic Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
January 2022
Overall Recruitment Status
Completed
Study Start Date
December 23, 2019 (Actual)
Primary Completion Date
June 1, 2021 (Actual)
Study Completion Date
June 1, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Aultman Health Foundation

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This is a clinical investigation to determine the efficacy of rectal versus intravenous acetaminophen in patients undergoing a minimally invasive hysterectomy. All women will receive acetaminophen either rectally or intravenously immediately postoperative, prior to extubation. Patient's will be randomly assigned to either the rectal acetaminophen or the intravenous acetaminophen group. Patient outcomes will be measured through a Numeric Rating Scale (NRS) from 0-10 for pain scores, and total opioid consumption measured in morphine milligram equivalent (MME) for the first 24 hours following surgery, or upon discharge, whichever comes first.
Detailed Description
Patient's undergoing major gynecologic surgery require effective postoperative pain management in order to enhance recovery and ultimately allow patients to return to their preoperative functional state. Traditionally, acute postoperative pain control has been achieved largely with the use of opioid medications. Excessive use of opioids can have adverse effects on the recovery process. Side effects include, but are not limited to dizziness, sedation, nausea/vomiting, respiratory depression, euphoria, constipation, and abuse. In addition, opioid monotherapy can delay post-operative ambulation, contribute to prolonged hospital stay and resumption of activities of daily living, and furthermore, have long-term sequelae for individuals as well as society at whole. Over the past decade, a multimodal approach to pain management has been explored in attempts to optimally treat acute postoperative pain. This approach is one of the keys to improving the recovery process. Acetaminophen is a non-opioid analgesic with a well-established safety and tolerability profile that is commonly used in multimodal approach to treating surgical pain. It is available in oral, rectal and Intravenous (IV) formulation. IV acetaminophen in particular is increasingly used for pain control after surgery as it has demonstrated a significant analgesic benefit in a variety of surgery types by reduction in pain intensity while decreasing total opioid use. Many studies have evaluated the efficacy of acetaminophen based on route of administration. A systematic review demonstrated that there is no clear indication for intravenous acetaminophen for patients who can tolerate an oral dosage as there was no difference if efficacy outcomes. This is valuable information as the cost of IV acetaminophen is exponentially more than the oral form. Although the oral form of acetaminophen is as efficient as controlling pain when compared to IV, and is notably cheaper, it is not the best option for the nauseated patient or patients whom are restricted from oral intake following surgery. Rectal acetaminophen is therefore a feasible alternative option in such patients. Data on the use of rectal acetaminophen in adults for postoperative pain management is limited. Pettersson and colleagues (2005) compared oral, rectal and IV paracetamol in day surgery patients. Although they demonstrated significantly higher plasma paracetamol concentrations in patients who received oral and IV formations at multiple time points, there was no difference in pain ratings. In another study, rectal paracetamol was shown to have a significant morphine-sparing effect after hysterectomy. At this time, there has been no study in the gynecologic literature to compare IV to rectal acetaminophen in terms of pain control and effect on overall opioid use in the acute post-operative period. The rationale for this study is to determine the optimal way of managing post-operative pain in gynecologic surgery in attempt to improve the overall recovery process. More specifically, this study will determine if the route of administration of acetaminophen has an effect on post-operative pain and use of opioid medication following a minimally invasive hysterectomy. The results of this study may guide post-operative pain management after gynecologic surgery, and help limit the amount of opioid use, while potentially reducing pharmacological costs for patients and hospitals.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Postoperative Pain, Opioid Use, Acetaminophen
Keywords
Postoperative Pain, Minimally-invasive Hysterectomy, Opioid Use, Acetaminophen, Hysterectomy

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
40 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Rectal acetaminophen
Arm Type
Active Comparator
Arm Description
Patients will receive two 650mg suppositories rectally of acetaminophen for a total dose of 1300mg at the end of surgery.
Arm Title
Intravenous acetaminophen
Arm Type
Active Comparator
Arm Description
Patients will receive one dose of 1000mg of acetaminophen, administered intravenously, at the end of surgery.
Intervention Type
Drug
Intervention Name(s)
Rectal acetaminophen
Intervention Description
Rectal 1300mg
Intervention Type
Drug
Intervention Name(s)
Intravenous acetaminophen
Intervention Description
Intravenous 1000mg
Primary Outcome Measure Information:
Title
Postoperative Pain: Standardized Pain Scale
Description
Post-operative pain control using a standardized pain scale from 0 (no pain) to 10 (worse pain) measured every 4 hours for the 24 hours, or discharge, whichever comes first. Time points were averaged for each participate and reported as a single value.
Time Frame
The first 24 hours following surgery, or upon discharge, whichever comes first.
Secondary Outcome Measure Information:
Title
Opioid Use
Description
Total amount of opioid rescue calculated by converting all opiates to Morphine Milligram Equivalents in the first 24 hours following surgery, or upon discharge, whichever comes first.
Time Frame
The first 24 hours following surgery, or upon discharge, whichever comes first.
Other Pre-specified Outcome Measures:
Title
Postoperative Pain: Standardized Pain Scale
Description
Post-operative pain control using a standardized pain scale from 0 (no pain) to 10 (worse pain) for the first 6 hours after surgery. Time points were averaged for each participate and reported as a single value.
Time Frame
The first 6 hours following surgery
Title
Postoperative Pain: Standardized Pain Scale
Description
Post-operative pain control using a standardized pain scale from 0 (no pain) to 10 (worse pain) for the first 12 hours after surgery. Time points were averaged for each participate and reported as a single value.
Time Frame
The 12 hours following surgery
Title
Opioid Use
Description
Total amount of opioid rescue calculated by converting all opiates to Morphine Milligram Equivalents in the first 6 hours following surgery
Time Frame
The first 6 hours following surgery
Title
Opioid Use
Description
Total amount of opioid rescue calculated by converting all opiates to Morphine Milligram Equivalents in the first 12 hours following surgery
Time Frame
The first 12 hours following surgery
Title
Estimated Blood Loss
Description
Total estimated blood loss in millilitres for the surgery
Time Frame
During the duration of the surgery, from start to end time, on average 1.5 hours
Title
Operative Time
Description
Operative time in minutes determined by the operating room record
Time Frame
From the start to end of the surgery

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Willing to consent Amendable to receive either rectal or intravenous acetaminophen Planned hospital stay for at least 24 hours. Exclusion Criteria: Patients unable to provide informed consent Patients with a history of regular opioid use prior to surgery based on their current home medication list Patients who have required regular opioid intake for the 7 days preceding surgery Patients with known hypersensitivity to acetaminophen Patients with a baseline preoperative liver function enzymes (AST and ALT) that are greater than twice the upper limits Unable to complete procedure as planned.
Facility Information:
Facility Name
Aultman Hospital
City
Canton
State/Province
Ohio
ZIP/Postal Code
44710
Country
United States

12. IPD Sharing Statement

Citations:
Citation
Cao X, et al. Effect of intraoperative or postoperative intravenous acetaminophen on postoperative pain scores and opioid requirements in abdominal and spinal surgery patients. Int J Clin Exp Med 11(4)4120-4125, 2018.
Results Reference
background
PubMed Identifier
26827847
Citation
Chou R, Gordon DB, de Leon-Casasola OA, Rosenberg JM, Bickler S, Brennan T, Carter T, Cassidy CL, Chittenden EH, Degenhardt E, Griffith S, Manworren R, McCarberg B, Montgomery R, Murphy J, Perkal MF, Suresh S, Sluka K, Strassels S, Thirlby R, Viscusi E, Walco GA, Warner L, Weisman SJ, Wu CL. Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain. 2016 Feb;17(2):131-57. doi: 10.1016/j.jpain.2015.12.008. Erratum In: J Pain. 2016 Apr;17(4):508-10. Dosage error in article text.
Results Reference
background
Citation
Sconzo Jr FR, Ramamoorthy S. The role of multimodal analgesia in colorectal surgery: a review of clinical data and case-based presentations featuring Ofirmev (acetaminophen) injections. Diseases of the Colon & Rectum 58(2):1-15, 2015.
Results Reference
background
PubMed Identifier
26157186
Citation
Jibril F, Sharaby S, Mohamed A, Wilby KJ. Intravenous versus Oral Acetaminophen for Pain: Systematic Review of Current Evidence to Support Clinical Decision-Making. Can J Hosp Pharm. 2015 May-Jun;68(3):238-47. doi: 10.4212/cjhp.v68i3.1458.
Results Reference
background
Citation
Petterson PH, Hein A, Owall A, Anderson RE, Jakobsson JG. Early bioavailability in day surgery: a comparison between orally, rectally, and intravenously administered paracetamol. J. of Ambulatory Surgery 12:27-30, 2005.
Results Reference
background
PubMed Identifier
10618939
Citation
Cobby TF, Crighton IM, Kyriakides K, Hobbs GJ. Rectal paracetamol has a significant morphine-sparing effect after hysterectomy. Br J Anaesth. 1999 Aug;83(2):253-6. doi: 10.1093/bja/83.2.253.
Results Reference
background

Learn more about this trial

Improving Post-Operative Pain and Recovery in Gynecologic Surgery

We'll reach out to this number within 24 hrs